Ojbindra KC

Dr. Ojbindra KC

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in Case Reports in Infectious Diseases
Verified
Journal Article
Open access
PDF file
SBSanjog Bastola
Sanjog Bastola
AHAlexandra Halalau
Alexandra Halalau
OKOjbindra KC
Ojbindra KC
AAAnju Adhikari
Anju Adhikari
Buschke–Löwenstein tumor of anorectal and perianal area is a rare but highly aggressive tumor, frequently associated with human papillomavirus (HPV) types 6 and 11. It often grows over years in immunocompetent patients and can be highly destructive to local tissue. We present a case of a 61-year-old male with HIV infection who presented with worsening pain and swelling in the anorectal area for one-year duration. Exam revealed a 15 × 10 cm mass in the anorectal area with multiple sinuses and fistulas. MRI revealed extension of the mass through pelvic structures. Biopsy showed squamous epithelium with koilocytes and histochemistry positive for P16, suggestive of HPV infection. Biopsy was negative for malignant transformation. He was not a candidate for surgery or radiation due to extensive infiltration of deeper structures and multiple fistulas. He refused interferon therapy, and diverting colostomy was placed for palliation. He presented two months later with overwhelming sepsis and died despite maximal medical therapy.

11 April 2022 in Journal of Community Hospital Internal Medicine Perspectives
Verified
Journal Article
Open access
PDF file
OKOjbindra KC
Ojbindra KC
PDPunya Hari Dahal
Punya Hari Dahal
MKManisha Koirala
Manisha Koirala
CKChandra Sekhar Kothagundla
Chandra Sekhar Kothagundla
EZEnas Al Zaghal
Enas Al Zaghal
RFRabih Fahed
Rabih Fahed
Denosumab is a human monoclonal antibody used to prevent skeletal-related events in prostate cancer patients with bone metastasis. Hypocalcemia ranging from mild to severe requiring prolonged hospitalization have been reported with the use of denosumab in patients with known risk factors such as chronic kidney disease, vitamin D deficiency, low parathyroid hormone level, hypomagnesemia, extensive osteoblastic metastasis, prior use of bisphosphonates, and comorbidities impairing calcium absorption. We present a case of a metastatic prostate cancer patient with extensive osteoblastic metastasis who developed severe recurrent hypocalcemia after a single dose of denosumab requiring a total of 58 days of high dose intravenous and oral calcium supplementations with three inpatient hospital admissions. This case highlights the risk of severe hypocalcemia associated with denosumab use even after the disease control with oncologic therapy and in the absence of other predisposing risk factors. This case also emphasizes monitoring calcium levels closely in all patients treated with denosumab. In the event of severe hypocalcemia, prolonged hospitalization should be expected, and discharge planning should be done meticulously, which may help decrease the overall length of hospital stay, readmissions, and morbidity.

1 July 2023 in Journal of Medical Cases
Verified
Journal Article
Open access
PDF file
OKOjbindra KC
Ojbindra KC
ASAnanta Subedi
Ananta Subedi
RSRakshya Sharma
Rakshya Sharma
Intravenous Immunoglobulin-Associated Severe Hemolytic Anemia

9 November 2022 in Journal of Community Hospital Internal Medicine Perspectives
Verified
Journal Article
Open access
PDF file
PDPunya Hari Dahal
Punya Hari Dahal
OKOjbindra KC
Ojbindra KC
MKManisha Koirala
Manisha Koirala
ANAfua Duker Ntem-Mensah
Afua Duker Ntem-Mensah
Several cases of Multisystem Inflammatory Syndrome in Adults (MIS-A) have been reported in adults since June 2020 after COVID-19 was first reported in December 2019. It was initially reported in children as MIS-C with Kawasaki-like disease, but a similar condition has been well recognized in adults. Although Mycoplasma co-infection has been reported with COVID-19, to our knowledge, concomitant Mycoplasma pneumoniae infection has not been reported together with MIS-A. We present a case of MIS-A with concomitant Mycoplasma pneumoniae infection. It is unclear if concomitant Mycoplasma infection resulted in increased severity of the patient’s illness or if it resulted in inciting the immune response in our patient who had recently recovered from COVID-19 infection. This case highlights the need to diagnose a patient with a typical presentation of MIS-A and any concomitant infection or illnesses

20 December 2021 in Cureus
Verified
Journal Article
Open access
OKOjbindra KC
Ojbindra KC
PDPunya H. Dahal
Punya H. Dahal
MKManisha Koirala
Manisha Koirala
ANAfua D. NtemMensah
Afua D. NtemMensah
Mycoplasma pneumoniae (M. pneumoniae) is a common cause of community-acquired pneumonia. It has been associated with many extrapulmonary manifestations that can present even in the absence of pulmonary signs and symptoms. Rhabdomyolysis and central nervous system (CNS) manifestations are rare extrapulmonary manifestations. These are infrequently reported in adults. We present a case of a healthy 32-year-old male who initially presented with signs and symptoms of community-acquired pneumonia and was treated with antibiotics. However, he continued to have generalized malaise, night sweats, diffuse joint pain, and myalgias and was subsequently noted to have rhabdomyolysis with elevated creatine kinase (CK) and myoglobin levels. Rhabdomyolysis was attributed to M. pneumoniae based on the recent history of upper respiratory tract infection and M. pneumoniae immunoglobulin M (IgM) serology positivity along with high M. pneumoniae IgG titer. The other causes of rhabdomyolysis were diligently excluded based on patient history and laboratory and clinical data. This immune-mediated rhabdomyolysis improved with intravenous hydration, doxycycline, and prednisone therapy. However, the patient developed progressive weakness with neuropathy, which required treatment with intravenous immune globulin (IVIG). This case highlights the need to maintain a high index of suspicion for rare extrapulmonary manifestations of mycoplasma infection, which could be life-threatening or cause significant morbidity; and in cases of severe extrapulmonary manifestations, the appropriate use of immunosuppressive/immunomodulatory therapy may lead to a better outcome.

20 April 2022 in Clinical Case Reports
Verified
Journal Article
Open access
OKOjbindra KC
Ojbindra KC
PDPunya Hari Dahal
Punya Hari Dahal
MKManisha Koirala
Manisha Koirala
ANAfua Duker Ntem‐Mensah
Afua Duker Ntem‐Mensah
Brucellosis typically presents with nonspecific symptoms of intermittent fever, night sweats, malaise, and arthralgia but can involve any organs as focal brucellosis. Intraabdominal involvement is rare. We report a case of acute cholecystitis associated with brucellosis with no history of exposure to risk factors in a non‐endemic area.